Description: Intech Biopharm Corporation focuses on developing and manufacturing generic drugs to treat respiratory diseases. It owns iLEF (inhaled low ethanol formulation), a metered dose inhaler platform for treating asthma and chronic pulmonary obstructive disease; and dry powder inhaler, a product comprises of blisters and capsules. The company offers its products under the SYN006, SYN010, SYN007, Synflutide, Duasma, Synvent, and SYN011 names. Intech Biopharm Corporation was founded in 2010 and is headquartered in Taipei, Taiwan.
Home Page: www.intechbiopharm.com
No. 36, Ruiguang Road
Taipei,
114
Taiwan
Phone:
886 2 7721 8877
Officers
| Name | Title |
|---|---|
| Mr. Weiwei Wu | Gen. Mang. |
| Hugues Hung | Chief Financial Officer |
Exchange: TWO
Country: TW
Currency: New Taiwan Dollar (NT$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 3.6678 |
| Price-to-Sales TTM: | 128.4774 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 87 |